Literature DB >> 9613348

Treatment of hyperthyroidism in young people.

T D Cheetham1, I A Hughes, N D Barnes, E P Wraight.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9613348      PMCID： PMC1717503          DOI： 10.1136/adc.78.3.207

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  36 in total

1.  Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.

Authors:  S D Sarkar; W H Beierwaltes; S P Gill; B J Cowley
Journal:  J Nucl Med       Date:  1976-06       Impact factor: 10.057

2.  Management of hyperthyroidism in children and adolescents.

Authors:  J I Hamburger
Journal:  J Clin Endocrinol Metab       Date:  1985-05       Impact factor: 5.958

3.  Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin.

Authors:  M Babcock; D de Silva; R Oaks; S Davis-Kaplan; S Jiralerspong; L Montermini; M Pandolfo; J Kaplan
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

4.  Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study.

Authors:  B M Dobyns; G E Sheline; J B Workman; E A Tompkins; W M McConahey; D V Becker
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

5.  Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism.

Authors:  A M Safa; O P Schumacher; A Rodriguez-Antunez
Journal:  N Engl J Med       Date:  1975-01-23       Impact factor: 91.245

6.  Ablative radioiodine therapy for hyperthyroidism: long term follow up study.

Authors:  P Kendall-Taylor; M J Keir; W M Ross
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-11

7.  Iodine-131: optimal therapy for hyperthyroidism in children and adolescents?

Authors:  J E Freitas; D P Swanson; M D Gross; J C Sisson
Journal:  J Nucl Med       Date:  1979-08       Impact factor: 10.057

8.  Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose.

Authors:  D S Cooper; D Goldminz; A A Levin; P W Ladenson; G H Daniels; M E Molitch; E C Ridgway
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

9.  Cancer risk after iodine-131 therapy for hyperthyroidism.

Authors:  L E Holm; P Hall; K Wiklund; G Lundell; G Berg; G Bjelkengren; E Cederquist; U B Ericsson; A Hallquist; L G Larsson
Journal:  J Natl Cancer Inst       Date:  1991-08-07       Impact factor: 13.506

10.  Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years.

Authors:  B M Lippe; E M Landaw; S A Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958
View more
  5 in total

1.  Atrioventricular block: an unusual complication of Graves' disease.

Authors:  Akintayo Adesokan; Trisha Vigneswaran; Michal Ajzensztejn; Sujeev Mathur
Journal:  BMJ Case Rep       Date:  2017-05-03

2.  "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.

Authors:  M C Vigone; E Peroni; M Di Frenna; S Mora; G Barera; G Weber
Journal:  J Endocrinol Invest       Date:  2019-11-12       Impact factor: 4.256

3.  Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016.

Authors:  Kanshi Minamitani; Hirokazu Sato; Hidemi Ohye; Shohei Harada; Osamu Arisaka
Journal:  Clin Pediatr Endocrinol       Date:  2017-04-22

4.  Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.

Authors:  Mariam Kourime; Sheena McGowan; Mabrouka Al Towati; S Faisal Ahmed; Graham Stewart; Scott Williamson; Iain Hunter; Malcolm D C Donaldson
Journal:  Arch Dis Child       Date:  2017-12-21       Impact factor: 3.791

5.  Effect of Addition of Thyroxine in the Treatment of Graves' Disease: A Systematic Review.

Authors:  Jun Li; Litao Bai; Fan Wei; Maoying Wei; Yao Xiao; Weitian Yan; Junping Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-25       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.